Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02TTL
|
|||
| Former ID |
DCL001179
|
|||
| Drug Name |
Debio 0932
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 1 | [1] | |
| Company |
Debiopharm
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H30N6O2S
|
|||
| Canonical SMILES |
CC(C)(C)CNCCN1C2=C(C(=NC=C2)N)N=C1SC3=CC4=C(C=C3N(C)C)OCO4
|
|||
| InChI |
1S/C22H30N6O2S/c1-22(2,3)12-24-8-9-28-14-6-7-25-20(23)19(14)26-21(28)31-18-11-17-16(29-13-30-17)10-15(18)27(4)5/h6-7,10-11,24H,8-9,12-13H2,1-5H3,(H2,23,25)
|
|||
| InChIKey |
RVJIQAYFTOPTKK-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 1061318-81-7
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Debiopharm (2011). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.